Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Ittmann

Showing results (11-20 of 125) with videos related to

Pageof 13
Sort By:
The Prostate|August 29, 2021
MEX3D is an oncogenic driver in prostate cancerLongjiang Shao, Jianghua Wang, Omer Karatas, et al.
The American Journal of Pathology|January 18, 2014
The senescence-associated secretory phenotype promotes benign prostatic hyperplasiaPaz Vital, Patricia Castro, Susan Tsang, et al.
Plos One|March 6, 2012
Frequent heterogeneous missense mutations of GGAP2 in prostate cancer: implications for tumor biology, clonality and mutation analysisYi Cai, Jianghua Wang, Chengxi Ren, et al.
Cell Cycle (Georgetown, Tex.)|February 3, 2009
Paths of FGFR-driven tumorigenesisVictor D Acevedo, Michael Ittmann, David M Spencer
Cancer Research|February 27, 2013
Endocrine fibroblast growth factor FGF19 promotes prostate cancer progressionShu Feng, Olga Dakhova, Chad J Creighton, et al.
The Prostate|May 7, 2004
FGF17 is an autocrine prostatic epithelial growth factor and is upregulated in benign prostatic hyperplasiaNathaniel Polnaszek, Bernard Kwabi-Addo, Jianghua Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 11, 2012
Targeting fibroblast growth factor receptor signaling inhibits prostate cancer progressionShu Feng, Longjiang Shao, Wendong Yu, et al.
Cancer Cell|February 21, 2012
Adult murine prostate basal and luminal cells are self-sustained lineages that can both serve as targets for prostate cancer initiationNahyun Choi, Boyu Zhang, Li Zhang, et al.
The Prostate|May 27, 2004
Interleukin-8 expression is increased in senescent prostatic epithelial cells and promotes the development of benign prostatic hyperplasiaPatricia Castro, Chen Xia, Lori Gomez, et al.
The Prostate|January 3, 2006
Sprouty4, a suppressor of tumor cell motility, is down regulated by DNA methylation in human prostate cancerJianghua Wang, Benjamin Thompson, Chengxi Ren, et al.
Pageof 13

Showing results (11-20 of 125) with videos related to

Sort By:
Pageof 13
The Prostate|August 29, 2021
MEX3D is an oncogenic driver in prostate cancerLongjiang Shao, Jianghua Wang, Omer Karatas, et al.
The American Journal of Pathology|January 18, 2014
The senescence-associated secretory phenotype promotes benign prostatic hyperplasiaPaz Vital, Patricia Castro, Susan Tsang, et al.
Plos One|March 6, 2012
Frequent heterogeneous missense mutations of GGAP2 in prostate cancer: implications for tumor biology, clonality and mutation analysisYi Cai, Jianghua Wang, Chengxi Ren, et al.
Cell Cycle (Georgetown, Tex.)|February 3, 2009
Paths of FGFR-driven tumorigenesisVictor D Acevedo, Michael Ittmann, David M Spencer
Cancer Research|February 27, 2013
Endocrine fibroblast growth factor FGF19 promotes prostate cancer progressionShu Feng, Olga Dakhova, Chad J Creighton, et al.
The Prostate|May 7, 2004
FGF17 is an autocrine prostatic epithelial growth factor and is upregulated in benign prostatic hyperplasiaNathaniel Polnaszek, Bernard Kwabi-Addo, Jianghua Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 11, 2012
Targeting fibroblast growth factor receptor signaling inhibits prostate cancer progressionShu Feng, Longjiang Shao, Wendong Yu, et al.
Cancer Cell|February 21, 2012
Adult murine prostate basal and luminal cells are self-sustained lineages that can both serve as targets for prostate cancer initiationNahyun Choi, Boyu Zhang, Li Zhang, et al.
The Prostate|May 27, 2004
Interleukin-8 expression is increased in senescent prostatic epithelial cells and promotes the development of benign prostatic hyperplasiaPatricia Castro, Chen Xia, Lori Gomez, et al.
The Prostate|January 3, 2006
Sprouty4, a suppressor of tumor cell motility, is down regulated by DNA methylation in human prostate cancerJianghua Wang, Benjamin Thompson, Chengxi Ren, et al.
Pageof 13